Connor, Clark & Lunn Investment Management Ltd. Alpine Immune Sciences, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
BUY
$17.75 - $41.6 $25,702 - $60,236
1,448 Added 12.16%
13,357 $529,000
Q4 2023

Feb 09, 2024
SELL
$8.54 - $20.22 $286,653 - $678,704
-33,566 Reduced 73.81%
11,909 $226,000
Q3 2023

Nov 13, 2023
SELL
$10.13 - $13.98 $11,325 - $15,629
-1,118 Reduced 2.4%
45,475 $520,000
Q2 2023

Aug 10, 2023
SELL
$6.84 - $11.91 $52,284 - $91,040
-7,644 Reduced 14.09%
46,593 $478,000
Q1 2023

May 09, 2023
SELL
$7.0 - $8.75 $28,497 - $35,621
-4,071 Reduced 6.98%
54,237 $418,000
Q4 2022

Feb 10, 2023
BUY
$5.45 - $7.35 $4,370 - $5,894
802 Added 1.39%
58,308 $428,000
Q3 2022

Nov 10, 2022
BUY
$6.89 - $9.39 $50,414 - $68,706
7,317 Added 14.58%
57,506 $414,000
Q2 2022

Aug 05, 2022
BUY
$6.71 - $9.52 $146,767 - $208,230
21,873 Added 77.25%
50,189 $427,000
Q1 2022

May 12, 2022
BUY
$6.41 - $13.89 $59,548 - $129,038
9,290 Added 48.83%
28,316 $254,000
Q4 2021

Feb 10, 2022
BUY
$10.41 - $13.95 $198,060 - $265,412
19,026 New
19,026 $264,000

Others Institutions Holding ALPN

# of Institutions
2
Shares Held
56.2K
Call Options Held
0
Put Options Held
0
View Full List

About ALPINE IMMUNE SCIENCES, INC.

ALPN Quotes by TradingView
  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email